Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wellstar International is a company primarily focused on the wellness and anti-aging sectors, operating largely through its European subsidiary, Wellstar GmbH. The company is best known for its Bionic Youth Activating System (BYAS), a range of handheld medical and cosmetic devices designed for skin rejuvenation, body contouring, and hair care. These devices utilize technologies such as iontophoresis, electrical muscle stimulation (EMS), and radiofrequency to deliver specialized cosmetic formulations. While the company was publicly traded in the United States under the symbol WLSI, it has become largely inactive in the public markets, though its product lines continue to be marketed in various international regions through direct-selling models.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wellstar International.